How to Track Symptoms With a J Pouch

To track symptoms with a j pouch, stop measuring yourself against the numbers you had before surgery and start measuring change from your own settled normal. The useful daily record is short: how many times you emptied in the day, how many at night, how long you could comfortably wait, whether emptying felt complete, any leakage, any blood, any measured fever, and every antibiotic course with its start and stop dates. Six bowel movements a day can be a perfectly healthy pouch. Six when your normal is four, with new urgency and an extra night trip, is a signal worth acting on. Night-time leakage and sleep have their own guide: sleeping with a j pouch.

That shift is the whole point of this guide. Almost every tracking template written for ulcerative colitis assumes a colon: it asks about stool form on the Bristol chart, counts bowel movements against a colon's normal, and treats blood as the main flare marker. After a proctocolectomy with an ileal pouch, frequency of five or more is expected, output is looser by design, and the inflammation you are watching for, pouchitis, does not announce itself the way colitis did. The Reddit threads behind this article keep returning to the same handful of questions: what is worth counting when going many times a day is normal, how do you tell pouchitis from a bad week, should night trips be logged separately, does calprotectin still mean anything, and what should you compare yourself to now.

This article answers those questions with the pouch literature itself. If you want the basics of what a j pouch is and how it differs from an ileostomy, our guide to tracking food triggers with an ostomy has the shared explainer, including the transit data showing that food takes longer to reach a pouch than a stoma bag. Here we deal with symptom tracking: what normal looks like in numbers, why your baseline matters more than any average, what to log and how to count it, how the definitions of pouchitis are built (and why your antibiotic dates are part of your diagnosis), what calprotectin can and cannot tell you, and when to stop logging and call.

One honest caveat up front. Much of the evidence on pouch function comes from a few large specialist centres, notably the Mayo Clinic and the Cleveland Clinic, with smaller cohorts from Norway, Israel, Japan and elsewhere. These are referral populations, and their averages may not describe someone whose pouch was made at a smaller hospital. Where we say "we could find no study", that reflects our searching of PubMed and Europe PMC, not proof that none exists.

Why the old UC markers stop working after a pouch

The short answer: the organ your old diary was watching is gone, so frequency, stool form and even blood carry different meanings now.

Before surgery, a rise from two bowel movements a day to eight was a clear flare signal, and stool form told you something about how much water your colon was absorbing. With an ileal pouch, the colon and almost all of the rectum have been removed, and the end of the small bowel has been folded into a reservoir and joined to the anus. Without the colon's water absorption, pouch output is looser than formed stool, and a higher daily count is the expected result of a healthy operation rather than a sign of disease.

Three practical consequences follow for anyone keeping a log:

1. Absolute frequency stops being a diagnosis. Eight a day can be normal for one person and a warning for another.
2. The Bristol chart mostly reads the same. Most pouch output sits at the loose end of the scale whatever is going on. A simple description of thickness tells you more (see the field table below).
3. The disease you are watching for has changed name and location. Ulcerative colitis lives in the colon and rectum. After a pouch, the main inflammatory problems are pouchitis (inflammation of the pouch itself), cuffitis (inflammation of the short strip of rectal tissue left at the join), and less often Crohn's-like disease of the pouch. Each can look similar from the outside, and none of them behaves exactly like the colitis you had.

That is why the most useful thing you can bring to this new situation is not a list of absolute thresholds but a well-recorded normal, so that a change stands out.

What "normal" looks like in numbers

Normal, in the large studies, means about five or six bowel movements in the daytime and one or two at night, with a lot of variation between people.

The longest follow-up comes from the Mayo Clinic, which mailed standardised questionnaires to its pouch patients every year. In 1,885 operations for ulcerative colitis followed for a mean of 11 years, mean daytime stool frequency rose from 5.7 at one year to 6.4 at 20 years, and night-time frequency from 1.5 to 2.0 (Hahnloser 2007). The same programme's 30-year report found daytime frequency moving from 5.7 at one year to 6.2 at 30 years, night-time from 1.5 to 2.1, and 93.3% of patients still with a functioning pouch at 30 years (Lightner 2017).

A Norwegian cohort of 315 patients, interviewed repeatedly over a mean of 12 years with 1,802 interviews in total, found a mean of 5.2 bowel movements in the day and 0.55 at night, and reported that this did not change with time (Wasmuth 2010). An older American study that followed 250 patients with yearly measurements reported that 24-hour stool frequency fell from 7.9 to 6.5 as the pouch's capacity increased over the years (Becker 1991).

These are averages, and individuals spread widely around them. Our guide to how many bowel movements a day are normal with a j pouch covers the frequency evidence in depth, including night-time counts, how numbers change in the first year and beyond, and what sets your own number. Here, the point is narrower: an average is a poor yardstick for any one person, which is why your own baseline, covered below, matters more.

What about overall outcomes? In the Cleveland Clinic's series of 3,707 primary pouch operations, functional outcome and quality of life were rated good or excellent in 95% of patients, and pouch failure occurred in 5.3% over a median follow-up of 84 months (Fazio 2013). Most pouches work well. The point of tracking is to notice early, and clearly, when yours stops doing what it usually does.

Your baseline beats any average

The single most useful thing you can record is two settled weeks of your own normal, because the scoring system clinicians use for pouchitis is built around change from your usual, not an absolute count.

The standard research tool is the Pouchitis Disease Activity Index (PDAI), developed at the Mayo Clinic in 1994. It combines a symptom score, an endoscopy score and a biopsy (histology) score on an 18-point scale (Sandborn 1994; Shen 2003). Because biopsies add cost and delay, the Cleveland Clinic group tested dropping the histology part. In 58 people with symptoms, the modified version (mPDAI), using symptoms plus endoscopy, matched the full index closely: a cut-point of 5 or more gave a sensitivity of 97% and specificity of 100% against the full PDAI (Shen 2003). Notice what that means for you: even the "simplified" score still needs a scope. There is no validated symptom-only score that diagnoses pouchitis.

The symptom items in the mPDAI are the interesting part for anyone keeping a log, because of how frequency is scored. In a 2024 University of Chicago analysis that set out the items, stool frequency was scored 0 for "usual", 1 for one to two stools a day more than usual, and 2 for three or more stools a day more than usual. Rectal bleeding scored 0 for none or rare and 1 for present daily. Faecal urgency or abdominal cramps scored 0 for none, 1 for occasional and 2 for usual. Fever over 37.8 °C scored 0 or 1 (Akiyama 2024). Add those up and the symptom part tops out at 6 points.

So the clinical score literally asks: how many more times a day than your usual? If you do not know your usual, neither you nor your clinician can answer that cleanly. People often reconstruct it from memory in the clinic, and memory tends to drift toward whatever the last few days were like.

How to record a baseline

A baseline is only useful if it is recorded at the right time and in a way you will repeat later.

• When: once your pouch has settled after takedown and you are well, not in the first weeks, not during an antibiotic course, and not during a stomach bug. If in doubt, ask your pouch team when they would expect your function to be stable.
• How long: two ordinary weeks. One week can be skewed by a single bad day or a holiday meal; two gives you a range.
• What: the same fields you will use later (see the next section), so you are comparing like with like.
• The summary you keep: a typical day count and its range, a typical night count, typical "can wait" time, how often emptying feels incomplete, and whether you ever leak. Write it at the top of your diary or in your phone's notes.

Then reset it when something big changes: a new long-term medicine, a pouch procedure, pregnancy, or a sustained change in your diet. A baseline from three years ago may no longer describe you.

What to log every day

The core daily record has six fields that take under a minute: day count, night count, urgency, completeness, leakage, and blood, plus a short notes line.

The choice of fields is not arbitrary. In the PROPS Delphi consensus, 195 patients, 62 colorectal surgeons and 48 gastroenterologists or nurse specialists went through three rounds of voting to agree which pouch symptoms matter most (Cavallaro 2021). Patients affirmed that frequency, incontinence, soiling and urgency matter, and the consensus also highlighted symptoms that earlier studies rarely measured: unpredictable bowel movements, altered patterns such as fragmentation, clustering and incomplete emptying, nocturnal symptoms, and perianal pain. The authors cite earlier work finding that clinicians tended to overestimate how much patients care about frequency and seepage and underestimate urgency and incomplete emptying. The study was funded by the Crohn's and Colitis Foundation's Surgical Research Network and recruited patients online, which its authors flag as a source of sampling bias.

You do not need every column every day. On a normal day, the first five fields and "none" for blood are enough. Use the rest when something is off. If you already keep an IBD diary, our guide on what to track in an IBD symptom diary covers the treatment record layer (medicines, dates, reasons for stopping) that sits alongside this.

Counting rules that make the numbers comparable

A count is only useful if you count the same way every time. Pick rules and stick to them:

• One sitting is one. If you go, get up, and go again within a couple of minutes, that is still one emptying. If you go back 20 or 30 minutes later because it did not feel finished, count it, and tick "incomplete". That return trip is the fragmentation signal patients told the PROPS researchers about.
• Count the "while I'm here" empties. Several people describe their pouch emptying when they go to pass urine. It is still an emptying; count it, or you will under-record on good days and see a false rise later.
• Night means between going to bed and getting up. Not midnight to 6 a.m. A 5 a.m. trip that ends your night counts as night.
• Do not count gas-only trips. Note them separately if they bother you. People with pouches describe learning, sometimes over years, to tell gas from stool (r/UlcerativeColitis), and a gas-only trip is a different event.

Why night-time gets its own column

Night counts move independently of day counts, and night leakage is common enough to need its own line.

In the Mayo 20-year cohort, frequent faecal incontinence was more common at night than in the day: the abstract reports it rising from 12% to 21% at night between one and 20 years, against 5% to 11% in the day (Hahnloser 2007). The Norwegian cohort found day and night incontinence in 13% and 21% of people respectively, with no change over time (Wasmuth 2010). Night leakage is not rare, and it is not automatically a sign of disease, but a new pattern of it is worth recording precisely.

A small Mayo physiology study gives one reason it happens. Comparing 22 people with full continence and 22 with night-time incontinence, the only clinical difference was stool frequency (a median of 6 versus 8 bowel movements in 24 hours), and overnight ambulatory measurement showed lower anal canal pressure during sleep in the incontinent group; standard daytime anorectal tests did not pick up the difference (Sarmiento 1997). That is 44 people at one centre, so treat it as a clue, not a rule. The practical takeaway for a log: a rise in total frequency and new night leakage may travel together, so record both.

Pouchitis or a bad week? What symptoms can and cannot tell you

You often cannot tell pouchitis from a bad week by symptoms alone, and the research says your doctor cannot either without looking. What the log can do is show a sustained change from your baseline, which is the trigger to ask.

The evidence on this is unusually blunt. In a Cleveland Clinic study of 46 people with a pouch, symptom, endoscopy and biopsy scores were all measured. A quarter (25%) of the people whose symptoms suggested pouchitis did not meet the diagnostic criteria, and the correlations between the symptom, endoscopy and histology scores were near zero, ranging from negative 0.26 to 0.20 (Shen 2001). The authors' conclusion is in their title: symptoms alone do not reliably diagnose pouchitis.

The same group then looked at 61 consecutive people with pouch symptoms. About half (31, or 50.8%) had pouchitis, 4 (6.5%) had cuffitis, and 26 (42.6%) had neither, a pattern they named irritable pouch syndrome (Shen 2002). Increased frequency, urgency and cramps were the most common symptoms in all three groups. Rectal bleeding was seen only in the cuffitis group, and no one in any group had a fever. Of those with pouchitis, 27 of 31 (87.1%) responded to a two-week antibiotic course. The irritable pouch group had no inflammation to treat, and 12 of 26 (46.2%) improved with antidiarrhoeal, anticholinergic or antidepressant treatment while the rest kept their symptoms.

The 2024 Chicago analysis found the same overlap from the other direction. Among 25 people whose pouch looked normal on endoscopy, 57% of those with data reported occasional or usual urgency or cramps, about 54% reported perianal pain or discomfort, and about 23% reported incontinence (Akiyama 2024). Those percentages come from the subset with each symptom recorded in their notes (for example, 8 of 14 for urgency or cramps), so the denominators are small. The authors' own conclusion was that symptoms had limited use in telling the inflammatory patterns apart. Funding came partly from NIH grants and a Chicago research foundation; one senior author reports consulting and speaking fees from several drug companies.

The practical guidance from the AGA's 2024 guideline is reassuring about what happens next. The panel felt routine pouchoscopy is not necessarily required before starting antibiotics for typical pouchitis symptoms or for infrequent episodes that respond to usual treatment, but that a scope is warranted for frequent recurrences, poor response to antibiotics, atypical symptoms, or suspected Crohn's-like disease (Barnes 2024). In other words, a clear record of typical symptoms that respond to treatment helps your team manage you without a procedure; a record of atypical symptoms, or of symptoms that do not settle, is what tells them it is time to look.

What different patterns might suggest (and why this is not a diagnosis)

The table below summarises patterns described in the studies above and the AGA guideline. It is here so you know which details to write down, not so you can label yourself.

The AGA guideline lists those alternative causes explicitly: C. difficile infection of the pouch, mechanical obstruction such as strictures at the join, the pouch inlet or the old stoma site, and non-relaxing pelvic floor dysfunction (Barnes 2024). Your log cannot distinguish them, but it can carry the clue (straining versus urgency, blood versus none, fever versus none) that points your team in the right direction.

Log every antibiotic course: it is part of your diagnosis

The most underrated pouch record is a simple list of antibiotic courses with dates, because the guideline definitions of chronic pouchitis are built on how you respond to antibiotics and how fast symptoms return.

Pouchitis is common. In US insurance claims data covering 594 people who had a pouch made for ulcerative colitis between 2007 and 2016, the cumulative incidence of pouchitis within two years was 48%; 29% had an isolated acute episode and 19% had recurrent pouchitis, and those with recurrent pouchitis used more outpatient, emergency and inpatient care (Barnes 2021). Over 30 years at Mayo, the cumulative probability of pouchitis was 80.2% (Lightner 2017). An episode is not a failure of your pouch. What matters is the pattern over time.

The AGA's 2024 guideline sets out pragmatic definitions anchored on antibiotic response (Barnes 2024):

• Intermittent pouchitis: isolated, infrequent episodes that improve with treatment (usually antibiotics) or on their own, followed by periods of normal pouch function.
• Chronic antibiotic-dependent pouchitis: episodes that respond to antibiotics but relapse shortly after stopping, typically within days to weeks, often needing repeated or continuous antibiotics or other therapies.
• Chronic antibiotic-refractory pouchitis: relapsing or continuous symptoms with an inadequate response to typical antibiotics, often needing escalation.

Notably, the panel chose not to define the dependent category by a number of episodes per year, explaining that it is a continuum: some people need three or four courses a year, others need antibiotics almost continuously. That differs from some patient information. Cleveland Clinic's patient page, for example, describes more than three relapses in a year as chronic antibiotic-dependent pouchitis (Cleveland Clinic). Both framings point at the same reality; the AGA simply puts more weight on how quickly symptoms come back than on a count.

Either way, the information your team needs is exactly what a log can hold. For each course, write down:

• the date symptoms started, and what they were compared with your baseline;
• the date you started the antibiotic, and its name;
• roughly when you felt better (days in);
• the date the course finished;
• the date symptoms came back, if they did.

That last gap, from finishing a course to symptoms returning, is the "relapses shortly after stopping" in the definition. People often cannot remember it a year later, and it is precisely the number that separates intermittent from dependent pouchitis. This is a record for your clinician, not a basis for changing any treatment yourself. Never start, stop or extend a course on the strength of your own log; that decision belongs with your pouch team.

The AGA guideline was fully funded by the AGA Institute, and its panel members disclosed their industry relationships in the document; several reported consulting fees from drug manufacturers.

Does calprotectin still mean anything with a pouch?

Yes, it still rises with pouch inflammation, but the cut-offs from colitis do not transfer and the AGA notes it is not routinely used in pouch care. Its best use is comparison with your own previous results.

If you have read our guide on what calprotectin levels mean for ulcerative colitis, the general literacy there still applies: it is a protein released by white blood cells in the gut lining, measured in a stool sample, and day-to-day variation is real. What changes with a pouch is the reference point.

The studies are consistent that calprotectin goes up with pouch inflammation, and inconsistent about where the line sits:

• Japan, early detection: in 60 people followed for a year after ileostomy closure, with samples every two months, 10 (17%) developed pouchitis. Their calprotectin was already elevated two months before diagnosis, and a cut-off of 56 µg/g had 100% sensitivity and 84% specificity for predicting pouchitis (Yamamoto 2015).
• Systematic review: seven studies with 256 patients proposed cut-offs ranging from 56 to 494 µg/g, with sensitivities from 57% to 100% and specificities from 38% to 92% (McKechnie 2020). The reviewers concluded it may be useful for ruling pouchitis out but that relying on biomarkers alone for diagnosis is unreasonable.
• Israel, cross-sectional: in 156 patients with 296 clinic encounters, median calprotectin was 208 µg/g in people without pouchitis and 550 µg/g in people with it. A level above 460 had over 80% specificity for significant endoscopic inflammation, and below 125 had over 80% specificity for endoscopic remission (Ollech 2022).
• New York, 2026: in 163 patients, median calprotectin was 50.5 µg/g with a normal pouch, 244 with acute pouchitis, 370.5 with chronic pouchitis and 231.5 with Crohn's-like inflammation. A threshold of about 167 separated inflamed from normal pouches with 94% specificity, and about 280 separated severe from milder endoscopic inflammation (Bronze 2026).

The AGA guideline acknowledges that calprotectin correlates with the PDAI and with endoscopic inflammation and can rise before a clinical diagnosis, but says its guideline did not systematically examine biomarkers in pouch disorders and that they are not routinely used in clinical practice (Barnes 2024).

For your log, that adds up to three habits:

1. Record every result with its date, the lab, the units, and what your symptoms were at the time. A result of 300 means more if you know your last three well-pouch results were 60, 80 and 70.
2. Do not read your number against the ranges printed for colitis. Ask your team what they consider a meaningful change for you.
3. Note the lab and test if they change. Then you and your team can judge whether a jump reflects a different test rather than a change in you.

Things that move your counts that are not pouch disease

A lot of day-to-day variation has ordinary causes, and logging them in the notes field stops you blaming your pouch for what dinner did.

• Meal timing and size. Night-time trips are one of the most common complaints in pouch threads, and the most repeated advice is eating the main meal earlier and not eating right before bed, although the person asking in one thread had already tried exactly that without much difference (r/IBD). One person eight weeks after takedown described typically needing to go 30 minutes to an hour after eating (r/UlcerativeColitis). We could find no trial of meal timing in pouch patients, so treat this as a widely shared workaround, not evidence, and test it on yourself with your log.
• Particular foods. People describe spicy, acidic and fried foods causing discomfort on the way out, and large raw salads causing trouble, while others eat almost anything (r/UlcerativeColitis). The method for testing a food one at a time is in our ostomy food trigger guide; the same design works with a pouch, with a longer timing window because food reaches a pouch more slowly than a stoma bag.
• Fluids. Without a colon, staying hydrated takes effort, a point made repeatedly in the AMA threads (r/UlcerativeColitis). Log drinks roughly and note dark urine or headaches.
• Medicines. Antidiarrhoeals, fibre supplements and other medicines your team has recommended change your counts. Log what you took and when, so a "good week" on a new routine is not mistaken for a change in the pouch. Do not adjust them based on this article; ask your team. Cleveland Clinic's patient page also lists frequent NSAID use among possible contributors to persistent pouch inflammation (Cleveland Clinic), which is worth noting in your log if you take them.
• Illness and travel. A stomach bug, a long flight or a disrupted routine can all shift counts for a few days. Mark those days so they do not distort your picture.

When to record your baseline after takedown

Record your formal baseline only once your counts have stopped improving for a few weeks, because function usually keeps changing for months after takedown.

One long-term study found 24-hour frequency falling from 7.9 to 6.5 as pouch capacity grew over the years (Becker 1991), and patient accounts describe very high counts in the first weeks that settle over months (r/UlcerativeColitis). The j pouch frequency guide covers that settling period in detail. For tracking, the rule is simple: in the early months, log for trend (is it better than last week?) rather than against a baseline. If your counts are not improving, or get worse after an initial improvement, raise it with your team.

Incomplete emptying and straining: the problems that hide behind "frequency"

If your counts are high because you keep going back, not because you keep needing to go, the problem may be emptying rather than inflammation, and the log should say so.

Evacuation problems after a pouch are probably more common than people realise. In a Mayo study of 111 people with a pouch who had been referred for anorectal testing, 83 (74.8%) met criteria for non-relaxing pelvic floor dysfunction, where the pelvic floor muscles tighten instead of relaxing during emptying; it was more common in people with chronic pouchitis (83.3% versus 62.2%), and of 22 who completed biofeedback therapy, 15 reported mild to moderate improvement and 5 significant improvement (Quinn 2017). Be careful with that 75%: these were people already referred for testing because of symptoms, so it says nothing about how common this is in everyone with a pouch.

The same group then tested 20 people who reported healthy pouch function. Six were excluded from the final "normal" analysis because of symptoms suggesting an evacuation disorder on a questionnaire, a structural abnormality on MRI, or both (Quinn 2022). In the remaining 14, the pouch emptied a mean of 74.2% of its contents by the end of the toilet phase of an MRI test. Even in a pouch that works well, "empty" is relative.

What to log if this sounds like you: whether you strained, roughly how long you sat, whether you went back within 30 minutes, and whether there was pain around the anus. Those details separate an emptying problem from an inflammation problem far better than a raw count. One person described seven or eight daily trips, rarely feeling fully empty, and limited results from pelvic floor physiotherapy, with symptoms centred on the anal canal rather than the pouch itself (r/UlcerativeColitis). That is exactly the kind of history a pouch specialist needs written down, because it is hard to convey in a ten-minute appointment.

Scores you can borrow (and what they cannot do)

Two published scores can give your log structure, but neither turns your diary into a diagnosis.

The mPDAI symptom items (frequency above usual, daily bleeding, urgency or cramps, fever over 37.8 °C) are the simplest borrowable structure, as described above. Scoring yourself weekly on those four items, out of 6, gives your team something they recognise. Just remember that the diagnostic cut-off of 5 applies to the combined symptom and endoscopy score, not to symptoms alone (Shen 2003).

The Ileoanal Pouch Syndrome Severity Score (IPSS) was built from the PROPS consensus to measure pouch function as patients experience it. It was developed in 298 patients recruited through IBD centres and patient websites, validated in a further 386, ranges from 0 to 145, predicted poor quality of life with an area under the curve of 0.83, and showed test-retest reliability (Cavallaro 2023). It measures function and its impact, not inflammation. If your team uses it, filling it in at the same point each quarter, alongside your daily log, is a good way to show long-term trends. We could not access its full item list, so we have not reproduced it here.

Why bother with any of this? Because pouch symptoms affect more than the bathroom. In the Crohn's and Colitis Foundation's Partners online cohort, 199 of 243 people with a pouch (82%) reported a history of pouch symptoms, and those with symptoms in the previous six months had clinically meaningfully worse scores for pain interference, depression, fatigue and social role satisfaction than those without (Barnes 2017). A log that captures sleep, tiredness and the plans you cancelled is not overkill; it is documenting the impact that the research says is real.

A worked example: three weeks of a pouch log

Here is how a log turns into something useful. This is an illustrative example, not a real patient.

Baseline (recorded over two settled weeks, eight months after takedown): 5 to 7 daytime emptyings, usually 6; 0 to 1 at night; can usually wait 30 minutes or more; incomplete emptying about once a week; no leakage; no blood.

Week 1: Days 1 to 4 normal. Day 5: 8 daytime, 1 night, note says "birthday dinner, late, wine". Day 6: back to 6. Reading: a one-off with an obvious cause. No action.

Week 2:

Reading: daytime frequency is now 3 to 4 above usual (the mPDAI would score that 2), urgency has gone from 30 minutes to under 5 (cramps and urgency now "usual", scoring 2), night trips have tripled and new night leakage has appeared. No blood, no fever over 37.8 °C. Symptom subscore 4 out of 6. This does not prove pouchitis, but it is a sustained, multi-field change from baseline over four days, which is the right time to call. The note "called pouch team" belongs in the log too.

Week 3: The team prescribes an antibiotic course (the log records the name and start date, Friday). Counts fall to 7 by Monday and 6 by Wednesday. The course ends the following Friday. The log keeps running, because the key question for the next few weeks is the one in the AGA definition: do the symptoms come back shortly after stopping?

The summary that goes into the treatment record is one line: "Episode 2 this year. Started [date]. Day 6 to 10, night 0 to 3, urgency under 5 min, night leak, no blood, no fever. Antibiotic [name] [start date] to [end date]. Better by day 3. Symptoms returned: not yet (checked at 4 weeks)."

Compare that with what most people can say from memory at a clinic appointment six months later: "I had a flare in the spring and they gave me antibiotics." The first version lets a clinician place you on the AGA definitions in seconds. The second does not.

Keeping it light enough to last

The log only works if you keep it going in the good months, because the good months are your baseline.

• Minimum viable version: day count, night count, and a one-word urgency rating, every day. Everything else only when something is off.
• Tally as you go, not at bedtime. A tally mark in your phone's notes, a paper card in your bathroom, or an app. Bedtime recall of a day with eight emptyings is not reliable.
• Weekly two-minute review: compare the week's typical count and night count with your baseline. If both are inside your range, you are done.
• Keep the antibiotic list separate, at the top or back of the diary, so it never gets lost among daily entries.

If you prefer paper or a spreadsheet, our guide to tracking symptoms without an app covers layouts that work; it was written for IBS but the paper and spreadsheet mechanics transfer. If you prefer an app, Clairop lets you log symptoms and meals in seconds, including by voice, and produces a one-page GI visit report with your bowel pattern, medicines and labs that you can take to an appointment (how it works). It does not diagnose pouchitis or replace your pouch team's judgement.

When a bad patch does arrive, our guide to tracking symptoms during a flare covers counting live versus scoring once a day, and how to reconstruct days you did not log, labelled honestly as estimates.

Myths worth dropping

"Ten times a day means pouchitis." Not on its own. Averages in large cohorts are five to six in the daytime, with wide individual spread (Hahnloser 2007; Wasmuth 2010). The validated score counts stools above your usual.

"No blood means no inflammation." Bleeding was confined to the cuffitis group in one study of 61 symptomatic people, and pouchitis itself did not come with bleeding there (Shen 2002). Absence of blood tells you very little.

"If I feel fine, my pouch is fine, and if I feel awful, it's pouchitis." Symptom scores and endoscopy scores barely correlated in the study that tested this (Shen 2001), and a large share of symptomatic people had no inflammation (Shen 2002). The AGA panel made no explicit recommendation on inflammation found on a scope in people without symptoms and noted that such patients may not routinely warrant treatment (Barnes 2024), which is a reminder that the two do not always line up in either direction.

"Chronic pouchitis means you really had Crohn's all along." A comment in one thread stated this as a rule (r/UlcerativeColitis). It is not. The AGA treats chronic antibiotic-dependent and antibiotic-refractory pouchitis as their own categories, separate from Crohn's-like disease of the pouch, while noting the two can coexist (Barnes 2024). In claims data, a new Crohn's diagnosis after a pouch for UC was recorded in 9.0% of patients (Barnes 2021). That is a real possibility worth discussing with your team, not an automatic conclusion.

"My calprotectin is over 50, so something's wrong." That threshold comes from colitis practice. In pouch studies, cut-offs range from 56 to 494, and one study's median in people without pouchitis was 208 (McKechnie 2020; Ollech 2022). Compare with your own history and ask your team.

"Once you have a pouch you're done with IBD care." Pouchitis has a 30-year cumulative probability of about 80% in the Mayo cohort (Lightner 2017), and the AGA guideline exists because pouch disorders need ongoing management. A healthy pouch can need very little attention for years, but it is still worth keeping a light log and a named team to call.

When to see a doctor promptly

Contact your pouch team or GP promptly, and urgently out of hours, for any of these:

• Bleeding that is more than a streak, clots, or bleeding with dizziness or a racing heart.
• A measured fever with pouch symptoms, or chills and feeling unwell.
• No output with cramping, a swollen abdomen or vomiting, which can mean a blockage.
• Signs of dehydration: very little or very dark urine, dizziness on standing, confusion, a very dry mouth, especially with high-volume watery output.
• Severe pelvic, abdominal or anal pain, or new discharge, a lump or pus near the anus, which can signal an abscess or fistula.
• A sustained change from baseline (more emptyings, worse urgency, new night trips or leakage) lasting more than a few days, or returning soon after an antibiotic course.
• Unexplained weight loss, persistent tiredness, or symptoms outside the gut such as joint pain, rashes or eye problems.

The thread where someone with a seven-month-old pouch described the toilet bowl turning red and asked whether to wait until morning (r/UlcerativeColitis) got one sensible reply: call the on-call service. That is the right instinct. Heavy bleeding is never a "wait and log it" situation.

Bringing the log to your pouch team

Your team will not read three months of daily rows, and they should not have to. Bring a one-page summary:

• Your baseline: typical day and night counts, can-wait time, leakage, recorded when.
• The current picture: the same numbers for the last two weeks, and the date the change started.
• The antibiotic list: each course with start, finish, response and relapse dates.
• Calprotectin results with dates, lab and the symptoms at the time.
• What you have changed: diet, timing, medicines your team recommended, anything new.
• Your questions, written down.

Our guide to building a symptom tracker summary for your doctor covers the handover format in detail, including why a 40-page export gets ignored and which chart formats survive a short appointment. For pouch care, the antibiotic list is the line most people wish they had kept.

The honest bottom line

A j pouch changes what normal means, so your diary has to change with it. Stop counting against the normal you had with a colon, record your own settled baseline, and track the things that move when something is wrong: day and night counts, how long you can wait, whether you empty fully, leakage, blood and measured fever. Keep a separate list of every antibiotic course with dates, because that list is how pouchitis gets classified.

Be honest with yourself about what the log can do. The research is clear that symptoms alone cannot tell pouchitis from cuffitis, an irritable pouch or an emptying problem, and that calprotectin thresholds for pouches are still being worked out. Your log is not a diagnosis. It is the evidence that something has changed, recorded precisely enough that your team can act on it quickly, and that is worth a minute a day.